0001213900-23-057083.txt : 20230714 0001213900-23-057083.hdr.sgml : 20230714 20230714160508 ACCESSION NUMBER: 0001213900-23-057083 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230712 FILED AS OF DATE: 20230714 DATE AS OF CHANGE: 20230714 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schroeder Timothy j CENTRAL INDEX KEY: 0001767226 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38793 FILM NUMBER: 231089149 MAIL ADDRESS: STREET 1: 2690 DEVILS BACKBONE ROAD CITY: CINCINNATI STATE: OH ZIP: 45233 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Inmune Bio, Inc. CENTRAL INDEX KEY: 0001711754 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 475205835 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 225 NE MIZNER BLVD, SUITE 640 CITY: BOCA RATON STATE: FL ZIP: 33432 BUSINESS PHONE: 8589643720 MAIL ADDRESS: STREET 1: 225 NE MIZNER BLVD, SUITE 640 CITY: BOCA RATON STATE: FL ZIP: 33432 4 1 ownership.xml X0407 4 2023-07-12 0 0001711754 Inmune Bio, Inc. INMB 0001767226 Schroeder Timothy j C/O INMUNE BIO INC. 225 NE MIZNER BLVD., SUITE 640 BOCA RATON FL 33432 1 0 0 0 1 Common Stock 2023-07-12 2023-07-12 4 S 0 10000 11.0085 D 82187 I See Footnote The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 22, 2021. The price reported in Column 4 is a weighted average price. These shares of common stock were sold in multiple transactions ranging from $11.00 to $11.10, inclusive. The reporting person undertakes to provide to Inmune Bio Inc., any security holder of Inmune Bio Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price in the range set forth above. These shares of common stock are held by CTI Holdings, a company of which Mr. Schroeder is the majority shareholder. Mr. Schroeder has voting and investment control over these shares. /s/ Timothy Schroeder 2023-07-14